RFG - Bristol Wealth Advisors’s AbbVie ABBV Stock Holding History

RFG - Bristol Wealth Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.14M	Sell	4,532 -2	-0%	-$430	0.28%	72
2026 Q1	$986K	Sell	4,534 -3	-0.1%	-$665	0.27%	72
2025 Q4	$1.04M	Sell	4,537 -125	-3%	-$28.5K	0.29%	70
2025 Q3	$1.08M	Buy	4,662 +2	+0%	+$407	0.31%	69
2025 Q2	$865K	Buy	4,660 +5	+0.1%	+$929	0.27%	78
2025 Q1	$975K	Buy	4,655 +174	+4%	+$33.8K	0.33%	65
2024 Q4	$796K	Buy	+4,481	New	+$824K	0.26%	80

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

RFG - Bristol Wealth Advisors's ABBV Position: Q2 2026 in Review

RFG - Bristol Wealth Advisors reduced its AbbVie (ABBV) stake by 0.04% in Q2 2026, selling an estimated $430 and leaving 4,532 shares worth $1.14M. The position accounts for 0.28% of the portfolio, ranked #72.

RFG - Bristol Wealth Advisors first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

RFG - Bristol Wealth Advisors held 4,532 shares of AbbVie worth $1.14M as of Q2 2026.
RFG - Bristol Wealth Advisors sold 2 AbbVie shares in Q2 2026, an estimated $430.
AbbVie made up 0.28% of RFG - Bristol Wealth Advisors's portfolio in Q2 2026, its #72 holding.
RFG - Bristol Wealth Advisors first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on RFG - Bristol Wealth Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.